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Abstract
 Background—Breast cancer awareness and early detection are limited in sub-Saharan Africa. 
Resource limitations make screening mammography or clinical breast exam (CBE) by physicians 
or nurses impractical in many settings. We aimed to assess feasibility and performance of CBE by 
laywomen in urban health clinics in Malawi.
 Methods—Four laywomen were trained to deliver breast cancer educational talksand conduct 
CBE. After training, screening was implemented in diverse urbanhealth clinics. Eligible women 
were ≥30 years, with no prior breast cancer or breast surgery, and clinic attendance for reasons 
other than abreast concern. Wo men with abnormal CBE were referred to a study surgeon. All 
palpable masses confirmed by surgeon exam were pathologically sampled. Patients with abnormal 
screening CBE but normal surgeon exam underwentbreast ultrasound con firmation. Additionally, 
50 randomly selected women with normal screening CBE underwent breast ultrasound, and 45 
different women with normal CBE were randomly assigned to surgeon exam.
 Results—Among 1,220 eligible women, 1,000 (82%) agreed to CBE. Lack of time (69%) was 
the commonest reason for refusal. Educational talk attendance was associated with higher CBE 
participation (83% vs 77%, p=0.012). Among 1,000 women screened, 7% had abnormal CBE. Of 
45 women with normal CBE randomized to physician exam, 43 had normal exams and two had 
axillary lymphadenopathy not detected by CBE. Sixty of 67 women (90%) with abnormal CBE 
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attended the referral visit. Of these, 29 (48%) had concordant abnormal physician exam. Thirty-
one women (52%) had discordant normal physician exam, all of whom also had normal breast 
ultrasounds. Compared to physician exam, sensitivity for CBE by laywomen was 94% (CI 
79-99%), specificity 58% (CI 46-70%), positive predictive value 48% (CI 35-62%), and negative 
predictive value 96% (CI 85-100%). Of 13 women who underwent recommended pathologic 
sampling of a breast lesion, two had cytologic dysplasia and all others benign results.
 Conclusions and relevance—CBE uptake in Lilongwe clinics was high. CBE by 
laywomen compared favorably with physician exam, and follow-up was good. Our intervention 
can serve as a model for wider implementation. Performance in rural areas, effects on cancer stage 
and mortality, and cost-effectiveness require evaluation.
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 1.1 Introduction
Breast cancer burden and mortality are high in low-and-middle-income countries (LMIC). 
The majority of newly diagnosed breast cancers in the United States are stage I or II, 
whereas most new breast cancers in LMIC are stages III or IV.1 Higher mortality in LMIC 
versus resource-rich settings is partly due to lack of breast cancer awareness and early 
detection. According to the 2003 World Health Survey, only 2% of women aged 40-69 in 
LMIC had received any breast cancer screening.2
Screening mammography is recommended in many high-income countries, but LMIC often 
lack infrastructure to implement this.3,4 International guidelines recommend alternative 
methods like clinical breast exam (CBE) in settings where mammography is not feasible.5-7 
Even in high-resource settings, annual CBE may be as effective as mammography in 
reducing breast cancer mortality.8-11 CBE can also be effective and cost-effective in LMIC 
settings.12-15
Given health workforce constraints in LMIC, task shifting has emerged as an important 
strategy for service delivery, which may be valuable for CBE implementation. Task shifting 
involves training lower cadres of health workers to perform tasks traditionally reserved for 
more highly trained individuals. In several countries, CBE has been effectively task-shifted 
to community health workers and lay volunteers, with increased detection of early-stage 
cancers and high levels of agreement with physician exam.16-20 Task shifting has also been 
important in achieving scale-up of antiretroviral therapy (ART) for HIV-infected individuals 
in sub-Saharan Africa (SSA).21 Comprehensive care for HIV in SSA has increasingly 
integrated other health services together with ART provision, and such bundling approaches 
may be similarly effective for cancer screening. In SSA to date, use of laywomen to conduct 
CBE has only been studied in Sudan, and this approach has not been studied in combination 
with other health services.
In Malawi, breast cancer is the third most common cancer among women.22 Patients are 
typically diagnosed at late stages with long symptom durations before diagnosis.23 The 
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Malawi Ministry of Health has prioritized early detection of breast and cervical cancer in the 
national strategic plan.24 However, no coordinated breast cancer screening program 
currently exists. We describe a pilot study training laywomen to perform CBE screening and 
promote breast cancer awareness among women attending various health clinics in the 
capital, Lilongwe. Our primary objectives were to assess feasibility and acceptability of this 
approach in urban settings, evaluate effectiveness of trained laywomen to conduct CBE, and 
describe CBE findings and follow-up among women screened. To our knowledge, this is the 
first breast cancer screening study in Malawi, and the first study from SSA to assess 
layperson-conducted CBE integrated with other health services.
 1.2 Methods
We identified and recruited four laywomen as Breast Health Workers (BHWs) by engaging 
local staff at the research site and breast cancer advocates. BHWs underwent a four-week 
training program, consisting of lectures, online modules, role-playing, case discussions, 
CBE using simulators and patients, and oral presentation practice.25 Ministry of Health 
trainers taught health communication, promotion, and education skills. Breast cancer 
survivors shared their experiences. Surgeons taught breast cancer epidemiology, prevention, 
detection, and clinical care. Surgeons and research staff taught research ethics, informed 
consent, data collection, and professionalism. 26
The CBE practice component used a simulator with 27 different tumors and lymph nodes of 
varying shapes and sizes in a torso with breasts, axillae, and supraclavicular regions. It also 
included benign masses and models with peau d’orange. We taught BHWs to visually 
inspect breasts for asymmetry, lumps, skin changes, edema, nipple retraction, discharge, or 
axillary swellings. To palpate the breast, we taught BHWs to use the pads of the middle 
three fingers with overlapping dime-sized circular movements. Palpation of axillary, 
infraclavicular, and supraclavicular lymph nodes was also taught. They also practiced CBE 
under supervision with each other and on consenting patients from outpatient clinics.25
BHWs learned to deliver a standardized breast cancer educational talk using a flip chart. To 
assess BHW competency in delivering educational talks prior to implementation of the 
program, three independent Malawian evaluators unaffiliated with the study evaluated each 
BHW during 12 talks, using a 5-point scale for 22 discrete topics grouped into four main 
areas: introduction, delivery, knowledge, and interactiveness.
Malawi and U.S. IRBs were obtained prior to study commencement. Screening was 
implemented in five clinics. Three clinics for outpatient general medicine, sexually 
transmitted infections, and colposcopy were on the campus of Kamuzu Central Hospital 
(KCH), one of two national teaching hospitals in Malawi. KCH is a 1000-bed public tertiary 
care hospital in Lilongwe, serving a catchment area of five million people throughout the 
central region. Two clinic sites for outpatient general medicine and antenatal/family 
planning were at another health center in Lilongwe. Eligibility criteria for study participation 
included female sex, age greater than 30 years, no personal history of breast cancer or breast 
surgery, and clinic attendance for reasons other than a breast concern. Two BHWs worked 
together at each site.
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BHWs began each day by giving a standardized breast cancer presentation to all patients in 
waiting rooms of the designated clinics. They documented the number of men and women 
attending the talk and any questions or comments raised. To minimize disruption to usual 
clinic operations, they approached patients to participate in the study only after their 
scheduled clinic visit. They kept a screening log to document eligibility, acceptance of CBE, 
and attendance of the educational presentation. If a woman was eligible and willing to 
participate, she was escorted to a private exam room where informed consent was obtained 
in the local language. The BHW collected information on patient demographics, breast 
cancer risk factors, and breast health history. She then performed a CBE. Any woman with 
an abnormal CBE or extensive breast concerns in the past 30 days by history was referred to 
a dedicated breast clinic at KCH staffed by study physicians. CBE abnormalities confirmed 
by physician exam were referred for fine needle aspiration (FNA) or core needle biopsy as 
appropriate. CBE abnormalities with normal physician exams were referred for breast 
ultrasound confirmation.
To evaluate diagnostic accuracy, we randomly assigned 50 women with normal CBE to 
undergo breast ultrasound at KCH, and another 45 women with normal CBE to physician 
exam. All patients referred for physician exam or additional diagnostic tests received 
reminder phone calls the day before by study staff. If a patient did not attend the scheduled 
visit or procedure, she was called to identify the reasons for non-attendance and to be 
rescheduled. Patients were given public transport reimbursements to attend follow-up visits.
Categorical baseline characteristics were analyzed using proportions and percentages, and 
compared between women with normal and abnormal screening CBE using chi-square and 
Fisher’s exact tests. The two-sided t-test was used to compare continuous variables between 
groups. We estimated sensitivity and specificity of BHW CBE using physician exam as the 
gold standard. Statistical significance was considered at an α-level of 0.05, and 95% 
confidence intervals (CIs) were provided where appropriate. All analyses were done using 
Stata SE Version 13.0 (StataCorp, College Station, TX).
 1.3 Results
From January to April 2015, 2,860 women and 1,435 men attended 175 talks in five clinics. 
The talks lasted approximately 30 minutes including discussion and were given daily. A total 
of 2,288 women attending the clinics were screened to participate in the study, of whom 
1,220 (53%) were eligible (Figure 1). The most common reasons for non-eligibility were age 
less than 30 years (n=1,020, 95%), clinic attendance for a breast concern (n=23, 2%), and 
history of breast surgery (n=12,1%). Among 1,220 eligible women, 1,000 (82%) agreed to 
participate in the study and undergo CBE. The most commonly stated reasons for study 
refusal were lack of time (69%) and feeling too ill or tired to participate (16%). Other 
reasons given were lack of interest (4%), tending to sick child (3%), and fear of cancer 
diagnosis (3%). Additional reasons were needing more time to decide, needing husband’s 
approval, desire for CBE but not wanting to participate in a research study, and recent CBE 
already performed, all of which were mentioned by less than 1% of women screened. 
Among eligible women, those who attended the educational talk (782/837, 83%) were 
significantly more likely to participate than eligible women who did not attend the talk 
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(217/282, 77%, p=0.012), although participation was high in both groups. Additionally, 
participation rates among eligible women varied significantly across the five clinics ranging 
from 71% in the colposcopy clinic to 86% in the sexually transmitted infections clinic 
(p=0.001).
A total of 1,000 women underwent CBE, of whom 933 (93%) had normal results and 67 
(7%) abnormal results (Table 1). The mean age was 37 years with 2% reporting a family 
history of breast cancer and 11% being postmenopausal. Characteristics were overall similar 
between women with normal and abnormal CBE. More women with normal CBE reported 
use of contraception compared to those with abnormal CBE (57% vs 30%, p<0.001). 
Additionally, more women with abnormal CBE reported breast concerns in the past 30 days 
compared to women with normal CBE (67% vs 6%, p<0.001).
Forty-five women with normal CBE were randomly assigned to undergo physician exam. Of 
these women, 43 (96%) had a normal physician exam, and two had a solitary abnormal 
axillary lymph node not detected by CBE. In Table 2, CBE done by BHWs is compared to 
physician exam, yielding a sensitivity of 94% (95% CI 79-99%), specificity of 58% (95% CI 
46-70%), positive predictive value of 48% (95% CI 35%-62%), and negative predictive 
value of 96% (95% CI 85-100%). Additionally, 50 women with normal CBE were randomly 
assigned to breast ultrasound, all of whom had normal findings.
Among 67 women with abnormal CBE, findings on exam or history leading to physician 
referral included the following, with some women referred for more than one reason: breast 
mass (n=38), lymphadenopathy (n=11), breast pain (n=11), nipple discharge (n=8), skin 
change (n=4), nipple/areolar change (n=4), breast asymmetry (n=1), breast swelling (n=1, 
and axillary mass (n=1). Sixty of 67 women referred for physician examination (90%) 
attended the recommended follow-up visit, of whom 29 (48%) had a concordant abnormal 
physician exam. Thirty-one women with abnormal CBE findings had a discordant normal 
physician exam, all of whom additionally had normal breast ultrasounds for confirmation.
Of 29 women with abnormal CBE and concordant abnormal physician exam, 19 were 
recommended to undergo biopsy or FNA of their lesion, including 15 women with breast 
lesions, and four with axillary masses or lymph nodes (Figure 2). Of 13 breast lesions 
sampled, two had dysplasia, and 11 were benign. Both women with dysplasia by cytology 
were advised to undergo excisional biopsy, but difficult social circumstances prevented 
completion of these procedures. Specifically, one woman could not be contacted by phone 
despite daily attempts for more than three months after her FNA results were reported. The 
second woman with cytologic dysplasia reported domestic issues interfering with her ability 
to return for surgery. Additionally, two women advised to have breast lesions biopsied based 
on abnormal physician exam decided not to undergo any additional testing despite extensive 
counseling. Of four women with abnormal axillary lymph nodes advised to undergo biopsy, 
one was diagnosed with benign tumoral calcinosis after excisional biopsy, one was 
diagnosed with HIV-associated Kaposi sarcoma, one declined further work-up, and one 
woman moved abroad before having biopsy. Ten women with abnormal CBE and 
concordant abnormal physician exam did not require a subsequent diagnostic procedure, and 
were managed conservatively based on physician recommendations as shown in Figure 2.
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We report a successful pilot program using trained laywomen to educate an urban population 
in Malawi about breast cancer and conduct CBE screening. Innovative features of our 
program include use of trained laywomen and integration of CBE with other health services 
in diverse clinical settings. Key findings were 82% uptake of CBE among eligible women, 
with higher uptake among women who attended educational talks. Compared to physician 
exam, sensitivity for CBE by BHWs was 94%, specificity 58%, positive predictive value 
48%, and negative predictive value 96%. Abnormal CBE occurred in 7% of 1000 women 
screened, with 90% of referred women attending recommended follow-up. Two possible 
breast cancers based on cytology and one HIV-associated Kaposi sarcoma were ultimately 
detected.
We achieved high acceptance of CBE among eligible women who were not planning to 
undergo CBE when they arrived in clinic. The major reason for CBE refusal was lack of 
time, which likely reflects the study design involving recruitment after regularly scheduled 
visits to avoid disrupting usual clinic operations. Due to high patient volume and few 
clinicians in all sites studied, long wait times often left women with little time to receive 
other health services after planned services. Refinement of our approach could include CBE 
screening during clinic visits or during waiting periods before the clinical encounter, which 
could improve acceptance rates. Additionally, we found CBE acceptance was higher among 
women who attended breast cancer educational talks delivered in waiting rooms, 
underscoring the importance of community education efforts alongside cancer screening.
Similar to a study in Sudan, our findings suggest that laywomen can be trained to educate 
communities about breast cancer and perform CBE screening competently. Excellent 
negative predictive value in our study for CBE by BHWs compared to physician exam 
suggests this approach can reliably identify women who do not require further evaluation. 
Positive predictive value was lower, but in an acceptable range for a screening intervention 
which would be implemented at a population level. The 7% abnormal CBE rate with 48% 
positive predictive value compared to physician exam suggests that referred women would 
not overburden higher-level health facilities in Malawi unnecessarily. Our abnormal CBE 
rate was comparable to other studies from the region, as was the detection rate for 
potentially cancerous lesions of the breast (2 per 1000 women screened).16 Use of trained 
laywomen to deliver cancer-screening interventions is less costly and more easily scaled up 
in LMIC settings than approaches that rely on nurses and clinicians. Additionally, laywomen 
may be more effective at engaging community women than medical professionals.27,28
Although we recruited women attending clinics for reasons unrelated to breast health, 10% 
of participants reported a breast concern within the last 30 days. This finding suggests that a 
significant burden of unaddressed, symptomatic breast disease may exist in Malawi. Our 
intervention may have allowed women to express health concerns for which they were not 
explicitly seeking care. By contrast, in high-income countries, breast cancer screening is 
largely aimed at detecting subclinical disease, since women typically know to seek medical 
assistance for breast symptoms and have appropriate places to seek care. In our study, 
finding many participants who reported prevalent breast symptoms during CBE is consistent 
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with our own prior findings of long symptom durations before breast cancer diagnosis in 
Malawi and extremely low breast cancer awareness among Malawian women.23 CBE scale-
up in Malawi could partially address symptomatic disease and even non-breast conditions in 
addition to asymptomatic breast disease. This is illustrated by a patient with Kaposi sarcoma 
diagnosed through our program and brought into care, health impacts of CBE may be greater 
in settings like Malawi than high-income countries.
Our study had several strengths. We used an intensive training program customized to the 
learning pace of our BHWs. Second, we implemented our program in diverse urban clinics 
in Lilongwe. Third, we had few exclusion criteria and findings may be generalizable to other 
ambulatory, urban populations in SSA. Fourth, we achieved high rates of follow-up and 
standardized management for referred patients in a dedicated breast clinic staffed by 
surgeons and pathologists.
There are also several limitations to our study. First, we selected and trained four highly 
motivated laywomen who were paid for their work. CBE programs may not perform 
similarly using unpaid volunteers. Second, CBE screening was implemented in urban 
settings, and results may not apply to rural areas. Moreover, the intervention targeted 
participants who were already attending clinics for other reasons and thus were already 
demonstrating health-seeking behavior. It is unclear how successful the program would be in 
community settings. High follow-up was partially achieved through phone calls and 
transport reimbursements for referred women, and less active follow-up would likely result 
in lower rates of completed referrals. However, even with these dedicated efforts, it is 
notable that both women with suspicious FNAs did not complete all recommended follow-
up procedures. Methods for optimizing adherence and retention must be further explored if 
our program is to be scaled up or replicated. Finally, our study lacked a control group and 
sufficient power to draw conclusions about the stage distribution of CBE-detected cancers. 
Larger, more definitive studies to assess clinical outcomes are needed.
In conclusion, acceptability and feasibility in Lilongwe were high for CBE screening 
performed by laywomen integrated with other health services. CBE conducted by BHWs 
compared favorably with physician exam, and high follow-up rates were achieved among 
women referred. Our intervention can serve as a model for wider implementation in Malawi 
and elsewhere in SSA, although performance in rural areas, effects on breast cancer stage 
distribution and mortality, and cost-effectiveness require further evaluation.
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Follow-up of referred women with abnormal physician exam after screening clinical breast 
exam.
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Table 2
Comparison of breast health worker clinical breast exam to physician exam
Breast health worker exam Physician exam normal Physician exam abnormal
Normal (n=45) 43 (95.5%) 2 (4.4%)
Abnormal (n=60) 31 (51.7%) 29 (48.3%)
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